Experience-dependent Retinogeniculate Synapse Remodeling is Abnormal in MeCP2-deficient Mice
Overview
Affiliations
Mutations in MECP2 underlie the neurodevelopmental disorder Rett syndrome (RTT). One hallmark of RTT is relatively normal development followed by a later onset of symptoms. Growing evidence suggests an etiology of disrupted synaptic function, yet it is unclear how these abnormalities explain the clinical presentation of RTT. Here we investigate synapse maturation in Mecp2-deficient mice at a circuit with distinct developmental phases: the retinogeniculate synapse. We find that synapse development in mutants is comparable to that of wild-type littermates between postnatal days 9 and 21, indicating that initial phases of synapse formation, elimination, and strengthening are not significantly affected by MeCP2 absence. However, during the subsequent experience-dependent phase of synapse remodeling, the circuit becomes abnormal in mutants as retinal innervation of relay neurons increases and retinal inputs fail to strengthen further. Moreover, synaptic plasticity in response to visual deprivation is disrupted in mutants. These results suggest a crucial role for Mecp2 in experience-dependent refinement of synaptic circuits.
A novel developmental critical period of orexinergic signaling in the primary visual thalamus.
Sanetra A, Jeczmien-Lazur J, Pradel K, Klich J, Palus-Chramiec K, Janik M iScience. 2024; 27(7):110352.
PMID: 39055917 PMC: 11269934. DOI: 10.1016/j.isci.2024.110352.
Activity-induced MeCP2 phosphorylation regulates retinogeniculate synapse refinement.
Tzeng C, Whitwam T, Boxer L, Li E, Silberfeld A, Trowbridge S Proc Natl Acad Sci U S A. 2023; 120(44):e2310344120.
PMID: 37871205 PMC: 10623012. DOI: 10.1073/pnas.2310344120.
Rupert D, Pagliaro A, Choe J, Shea S J Neurosci. 2023; 43(40):6745-6759.
PMID: 37625856 PMC: 10552946. DOI: 10.1523/JNEUROSCI.0838-23.2023.
Activity-Dependent Synapse Refinement: From Mechanisms to Molecules.
Nagappan-Chettiar S, Burbridge T, Umemori H Neuroscientist. 2023; 30(6):673-689.
PMID: 37140155 PMC: 11584027. DOI: 10.1177/10738584231170167.
Mykins M, Layo-Carris D, Dunn L, Skinner D, McBryar A, Perez S J Neurosci Res. 2023; 101(8):1236-1258.
PMID: 37026482 PMC: 10332853. DOI: 10.1002/jnr.25190.